Physician profile
Rakhee Ajmera
NPI 1255658902
$1,487.11
in general payments reported to CMS, 2019-2025
16 companies · $509 in 2025
The $509 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.05 · 2023: $228 · 2024: $726 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,463.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $329.04 | 2021-2025 | |
| Pfizer INC. | $286.82 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $283.56 | 2023-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $198.75 | 2023-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $99.06 | 2024 | Xarelto |
| Novo Nordisk INC | $55.28 | 2024-2025 | Ozempic, Rybelsus |
| Kiniksa Pharmaceuticals International, Plc | $46.87 | 2024 | Arcalyst |
| Abbott Laboratories | $28.32 | 2023 | Cardiomems |
| Merck Sharp & Dohme LLC | $26.52 | 2024 | Verquvo |
| Esperion Therapeutics, INC. | $26.28 | 2024 | Nexletol |
| Edwards Lifesciences Corporation | $21.19 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Regeneron Healthcare Solutions, INC. | $20.78 | 2024 | Evkeeza |
| Boston Scientific Corporation | $19.12 | 2024 | Watchman Access System |
| Amgen INC. | $17.33 | 2024 | Repatha |
| Lilly USA, LLC | $14.19 | 2025 | Zepbound |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $14.00 | 2025 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakhee Ajmera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.